18 / 28
Romanel et al Sci Transl Med. 2015
AR copy number did not change from baseline to progression
AR aberrant: less likely to respond and poorer outcomes
Resistance in 30% of patients was associated with an AR mutation
- Several months prior to clinical/radiological progression